During the spring the oncological clinic at UAS will evaluate RealQ Breast Cancer in regard to the treatment of metastatic breast cancer, this under the direction of chief physician and director of breast cancer Henrik Lindman. The first interim report will be published/made public in connection with SOF’s (Swedish Oncology Association) spring meeting in the middle of March 2009. Clinics need a decision support tool for doctors in their everyday work which also gathers key data in regard to the treatment of cancer patients in a database connected to the clinic.
The clinic will also offer its patients the opportunity to enter side-effects digitially prior to their doctor’s visit, something which decreases administration and makes the patient meeting more efficient for the doctor. Parallel to the evaluation from the clinic two academic papers have been planned to validate and document the project. A student from the institution for societal pharmacy at Uppsala University shall focus on the doctor and nurse perspective from a validity point of view, possibilities for pharmaceutical-specific reports as well as user-friendliness. A nursing student taking the specialist oncology stream shall primarily evaluate the process and the results from the side-effects reported by patients.
For more information, please contact Jenny Söderberg.
